Singulex Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Singulex Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6566
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and physicians in identifying the biomarkers of disease. Singulex’s SMC technology offer ultrasensitive lab testing services for facilitating proactive health management. The company also provides immunoassay kits and reagents and immunoassay systems. It offers services such as clinical lab testing, patient lab testing, wellness programs, clinical laboratory consulting and billing and client services. The company’s technology is used for medical practice or clinical diagnostics and scientific research applications. Singulex is headquartered in Alameda, California, the US.

Singulex Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Singulex Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Singulex Raises US$55 Million In Financing Round 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Partnerships 14
Singulex Enters into Licensing agreement with Thermo Fisher Scientific 14
Singulex Enters into Licensing Agreement with Grifols 15
Singulex Enters into Agreement with Qiagen 16
Singulex Forms Joint Venture with Technology Foundation STW 17
Singulex Enters into Development Agreement with CHDI Foundation 18
Singulex Enters Into Co-Development Agreement With Tecan 19
EMD Millipore Enters into Licensing Agreement with Singulex 20
Equity Offering 21
Grifols Invests USD50 Million in Singulex 21
Singulex Withdrawn IPO For Up To US$86 Million 22
Singulex Inc – Key Competitors 23
Singulex Inc – Key Employees 24
Singulex Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Singulex Inc, Medical Equipment, Key Facts 2
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Deals By Market, 2012 to YTD 2018 8
Singulex Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Singulex Raises US$55 Million In Financing Round 10
Singulex Raises US$12 Million In Series G Financing 11
Singulex Raises US$15.3 Million In Venture Financing 12
Singulex Secures USD15.34 Million in Series F Round of Fundingq 13
Singulex Enters into Licensing agreement with Thermo Fisher Scientific 14
Singulex Enters into Licensing Agreement with Grifols 15
Singulex Enters into Agreement with Qiagen 16
Singulex Forms Joint Venture with Technology Foundation STW 17
Singulex Enters into Development Agreement with CHDI Foundation 18
Singulex Enters Into Co-Development Agreement With Tecan 19
EMD Millipore Enters into Licensing Agreement with Singulex 20
Grifols Invests USD50 Million in Singulex 21
Singulex Withdrawn IPO For Up To US$86 Million 22
Singulex Inc, Key Competitors 23
Singulex Inc, Key Employees 24
Singulex Inc, Joint Venture 25

List of Figures
Singulex Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Singulex Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Singulex Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Singulex Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Singulex Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Singulex Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gas Sensing Technology Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Gas Sensing Technology Corp (Gas Sensing Technology), doing business as Welldog, a subsidiary of The Blue Sky Group Inc, is oil and gas company that provides technologies and reservoir analysis services. The company offers shale oil and gas, coal seam gas, coal mining, conventional oil and g …
  • Serica Energy Plc:企業のM&A・事業提携・投資動向
    Serica Energy Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Serica Energy Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Planet Gas Ltd (PGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Planet Gas Ltd (Planet Gas) is an upstream oil and gas company that offers acquisition, exploration, production and development of oil and gas properties in the US. The company holds interests in conventional and unconventional oil and gas projects in Australia. It projects explores for coal …
  • Akorn Inc (AKRX):企業の財務・戦略的SWOT分析
    Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • National Cancer Centre Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary National Cancer Centre Singapore (NCCS) is a cancer research centre that offers research, education, clinical services, and patient care services. The centre offers services such as medical oncology, oncologic imaging, palliative medicine, pharmacy, psychosocial oncology, public education, r …
  • Genera Biosystems Ltd (GBI):製薬・医療:M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Guangshen Railway Company Limited:戦略・SWOT・企業財務分析
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Meritor, Inc.:企業の戦略・SWOT・財務分析
    Meritor, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meritor, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Premiere Global Services, Inc.:企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Innovate Biopharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Innovate Biopharmaceuticals Inc (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company’s pipeline product includes INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 in phase …
  • MMRGlobal Inc (MMRF):企業の財務・戦略的SWOT分析
    MMRGlobal Inc (MMRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bank of Maharashtra:企業の戦略・SWOT・財務情報
    Bank of Maharashtra - Strategy, SWOT and Corporate Finance Report Summary Bank of Maharashtra - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-euphoric cannabinoid, formulate …
  • Teledyne Technologies Incorporated (TDY)-石油・ガス分野:企業M&A・提携分析
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of instrumentation, digital imaging products and software, aerospace and defense electronics and engineered systems. The company provides electronic subsystems, monitoring instrumentation for marine and environmental applications, h …
  • Emco Ltd (EMCO):電力:M&Aディール及び事業提携情報
    Summary Emco Ltd (Emco) is a power company that manufactures and markets electrical products and solutions. The company's products include transformers, substations, energy metering systems, and transmission towers and lines. Its transformers comprise furnace transformers, distribution transformers, …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Charles River Laboratories International Inc (CRL):製薬・医療:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Carter Holt Harvey Ltd:企業の戦略・SWOT・財務情報
    Carter Holt Harvey Ltd - Strategy, SWOT and Corporate Finance Report Summary Carter Holt Harvey Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆